Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow LSA on Bluesky
  • Follow lsa Template on Twitter
Research Article
Transparent Process
Open Access

Mitochondrial impairment and intracellular reactive oxygen species alter primary cilia morphology

View ORCID ProfileNoah Moruzzi  Correspondence email, Ismael Valladolid-Acebes, Sukanya A Kannabiran, Sara Bulgaro, Ingo Burtscher, Barbara Leibiger, Ingo B Leibiger, Per-Olof Berggren, Kerstin Brismar
Noah Moruzzi
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
2Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD), Neuherberg, Germany
Roles: Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noah Moruzzi
  • For correspondence: noah.moruzzi@ki.se
Ismael Valladolid-Acebes
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Formal analysis, Validation, Investigation, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sukanya A Kannabiran
2Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD), Neuherberg, Germany
4Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Roles: Investigation, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Bulgaro
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Investigation, Visualization, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingo Burtscher
2Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD), Neuherberg, Germany
Roles: Resources, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Leibiger
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Validation, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingo B Leibiger
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Validation, Methodology, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per-Olof Berggren
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Resources, Funding acquisition, Visualization, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Brismar
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Roles: Resources, Supervision, Funding acquisition, Visualization, Project administration, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Published 14 September 2022. DOI: 10.26508/lsa.202201505
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Mitochondria relationship with the cilia and effect of mitochondria inhibitors on IMCD3 ciliation.

    (A) Representative image of live recording of stable IMCD3 ARL13b-RFP-Mito-PAGFP at confluence. The transparent white circles indicate the radius of 2 μM in the xy dimensions from the base of the cilia. The below images represent slices of the z dimension to show the mitochondria location within the cell. The dashed lines show the distance between the start site of ARL13b and the location of that particular mitochondria indicated with the +. The measurements where performed with Imaris which allows to draw lines in between z-stack and measurements of the distance between two different points in 3D which are reported in the figures. Scale bar = 2 μM. (B) Representative image of live recording of stable IMCD3 ARL13b-Venus loaded with 25 nM TMRE. The transparent white circle/ellipse indicates the mitochondria within the radius of 2 μM from the base of the cilia. (A, B, C, D, E) The image plane was rotated using Imaris to show the mitochondrial subset close to the cilium. The dashed lines show the distance between the start site of ARL13b and the location of that particular mitochondria indicated with the +. Scale bar = 3 μM. (C) Mitochondrial membrane potential of mitochondria within <2 μm from the cilium compared with the overall cell mitochondrial network measured with TMRE in IMCD3 ARL13b-Venus stable cell line. Data are represented by mean + CI; n = 3. (D) Representative image of IMCD3 cell line treated for 48 h with DMSO vehicle or 100 nM of rotenone. Cilia stained with anti-acetylated α-tubulin are indicated with white arrows, whereas not counted cytokinetic bridges in dividing cells are indicated with yellow arrows. (E) Quantification of dose-dependent effect of rotenone on number of ciliated IMCD3 cells. Data are represented by mean + SD; n ≥ 2. (F) ATP/ADP ratio in IMCD3 cells treated 48 h with DMSO vehicle, 25 nM rotenone or 50 nM oligomycin. Data are represented by mean + SD; n ≥ 3. (G) Quantification of IMCD3 ciliated cells treated as above. Data are represented by mean + SD; n = 4. (H) Representative WB image of IFT88 protein in IMCD3 cells treated as above. Quantification is represented by mean + SD; n = 4. Legend: Black empty = DMSO control; Black = rotenone 25 nM; Red = oligomycin 50 nM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**) or <0.001 (***). Rotenone versus oligomycin: P < 0.05 (#).

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. Mitochondria relationship with the basal body and effects of rotenone and oligomycin on IMCD3 cilia.

    (A) Representative image of live recording of IMCD3 with Mitotracker DeepRed. The transparent white circle/ellipse indicates the mitochondria within the radius of 2 μM from the base of the cilia. (B) Example of image rendering with Imaris software used for TMRE intensity quantification. Rendering colors: mitochondria (green), cilium (red), subset of selected mitochondria (yellow) within 2 μM distance from the primary cilium. (C) Mitochondrial membrane potential of mitochondria within <2 μm from the cilium compared with the overall cell mitochondrial network measured with TMRE in IMCD3 ARL13b-Venus stable cell line. Data are represented by mean + CI; all technical replicates n = 15. (D) Quantification of dose-dependent effect of rotenone on number of ciliated IMCD3 cells. Data are represented by mean + CI; all technical replicates n = 16. (E) ATP/ADP ratio in IMCD3 cells treated 48 h with DMSO vehicle, 25 nM rotenone, or 50 nM oligomycin. Data are represented by mean + CI; all technical replicates n > 5. (F) Quantification of IMCD3 ciliated cells treated as above. Data are represented by mean + CI; all technical replicates n > 16. (G) Representative WB image of IFT88 protein in IMCD3 cells treated as above. Quantification is represented by mean + CI; all technical replicates n > 7. Legend: Black empty = DMSO control; black = rotenone 25 nM; red = oligomycin 50 nM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**), or <0.001 (***). Rotenone versus oligomycin: P < 0.05 (#).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Reactive oxygen species, but not cells cycle and apoptosis, are in part responsible for decreased ciliation in IMCD3.

    (A) Quantification of Mitosox intensity in IMCD3 cells treated for 48 h with DMSO vehicle, 25 nM rotenone, or 50 nM oligomycin. Data are represented by mean + SD; n = 6. (B) Quantification of DCFDA intensity in IMCD3 cells treated as above. Data are represented by mean + SD; n = 5. (C) Quantification of cilia number in IMCD3 cells treated for 48 h with 25 nM of rotenone in the presence of antioxidants (Tiron + Vit.C 1 mM, retinoic acid 1 μM). Data are represented by mean + CI; n = 4. (D) Cell cycle analysis in IMCD3 cells treated as above. In the inset is displayed a representative image of cell cycle plot in control cells. Data are represented by mean + CI; n = 4. (E) Analysis of apoptotic and dead IMCD3 cells treated as above normalized per 100 events of DMSO treated cells. In the inset is displayed a representative plot of control cells. Staurosporin 6 μM has been added 2 h prior the trypsinization as positive control. Data are represented by mean + SEM; n ≥ 2. Legend: Black empty = DMSO control; black = rotenone 25 nM; red = oligomycin 50 nM; blue = staurosporine 6 μM; orange = Tiron + Vit.C 1 mM; pink = Retinoic acid 1 μM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**), or <0.001 (***). Rotenone versus oligomycin: P < 0.05 (#), <0.01 (##), or <0.001 (###).

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Reactive oxygen species (ROS) are partly responsible for decreased number of ciliated IMCD3 cells.

    (A) Quantification of Mitosox intensity in IMCD3 cells treated for 48 h with DMSO vehicle, 25 nM rotenone, or 50 nM oligomycin. Data are represented by mean + CI; n > 11. (B) Representation of flow cytometric histogram of IMCD3 cells treated 48 h with DMSO vehicle, 25 nM rotenone, or 50 nM oligomycin stained with Mitosox. Green: unstained, red: control, blue: rotenone, orange: oligomycin. (C) Representation of flow cytometric histogram of IMCD3 cells treated as above and stained with DCFDA. Green: unstained, red: control, blue: rotenone, orange: oligomycin. (D) Quantification of DCFDA intensity in IMCD3 cells treated as above. Data are represented by mean + CI; n = 10. (E) Quantification of dose-dependent effect of 48-h treatment with TBOOH on number of ciliated IMCD3 cells. Data are represented by mean + CI; n = 15. (F) Quantification of DCFDA intensity in IMCD3 cells after 48-h treatment with different doses of TBOOH. Data are represented by mean + CI; n = 6. (G) Quantification of the effect of 48 h treatment with 50 μM paraquat on number of ciliated IMCD3 cells. Data are represented by mean + CI; n = 14. (H) Quantification of cilia number in IMCD3 cells treated for 48 h with 25 nM of rotenone in the presence of antioxidants (Tiron + Vit.C 1 mM, retinoic acid 1 μM). Data are represented by mean + CI; n > 15. (I) Cell cycle analysis in IMCD3 cells treated as above. In the inset is displayed a representative image of cell cycle plot in control cells. Data are represented by mean + CI; n > 8. (J) Analysis of apoptotic and dead IMCD3 cells treated as above normalized per 100 events of DMSO treated cells. In the inset is displayed a representative plot of control cells. Staurosporin 6 μM has been added 2 h prior the trypsinization as positive control. Data are represented by mean + CI; n = 9. Legend: Black empty = DMSO control; black = rotenone 25 nM; red = oligomycin 50 nM; blue = staurosporine 6 μM; orange = Tiron + Vit.C 1 mM; pink = Retinoic acid 1 μM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**), or <0.001 (***). Rotenone versus oligomycin: P < 0.05 (#), <0.01 (##), or <0.001 (###).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Ciliation is impaired in kidney of diabetic nephropathy mouse model db/db.

    (A) Non-fasting plasma creatinine in wild-type and db/db mice at 8 (n = 4) and 24 (n = 3) wk of age. Data are represented by mean + SEM. (B, C) Representative morphological kidney sections (20 μm) counterstained with hematoxylin–eosin of 8- and 24-wk wild-type and db/db mouse. Scale bar = 1 mm in whole kidney pictures and 100 μm in blow up pictures. (D) Representative single stack images of kidney sections stained with ciliary acetylated tubulin (green) and collecting duct cells aquaporin-2 (red). Nuclei (blue) were counterstained with DAPI. (E) Percentage of ciliated collecting duct cells in wild-type and db/db mice at 8 and 24 wk of age. Data represent three medullary images (upper, middle, and lower kidney) in duplicates for each mouse (n = 4). Minimum 10 collecting duct cells have been counted for each image. Data are represented by median+IQr and range (n = 4). Statistical test ANOVA+Bonferroni. (F) Cilia length of collecting ducts cells in wild-type and in db/db mice at 8 and 24 wk of age. Data are represented by median+IQr and range (n = 4). Statistical test ANOVA+Bonferroni. (G) Gene expression measured by qPCR in wild-type and db/db mice at 8 and 24 wk of age. Data are represented by mean + SD (n ≥ 3). (H) Flux analysis recording of the oxygen consumption rate from complex I+III+IV, II+III+IV, or complex IV only of disrupted mitochondrial from frozen samples extracted from the kidney of wild-type and db/db mice at 8 and 24 wk of age. Data are represented by mean + SEM (n ≥ 3). (I) Oxygen consumption rate from complex I+III+IV, II+III+IV, or complex IV of disrupted mitochondrial from frozen samples extracted from kidney of wild-type and db/db mice at 8 and 24 wk of age. Data are represented by mean + SD (n ≥ 3). (J) Representative single stack images of kidney sections stained with ciliary acetylated tubulin (green) and distal tubules cells Na+-K+ ATPase (red). Nuclei (blue) were counterstained with DAPI. Legend: Gray = wild-type mice (wt/wt); black empty = db/db. (K) Percentage of ciliated distal tubules cells in wild-type and db/db mice at 8 and 24 wk of age. Data are represented by median+IQr and range (n = 4). Statistical test ANOVA+Bonferroni; statistical significance between wild-type versus db/db: P < 0.05 (*), <0.01 (**), or <0.001 (***).

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3. Metabolic features, circulating hormones and cilia length in kidneys of db/db mouse model.

    (A) Body weight of female wild-type and db/db mice at 8 and 24 wk of age (n = 4). (B) Non-fasting plasma leptin in wild-type and db/db mice at 8 (n = 4) and 24 (n = 3) wk of age. (C) Non-fasting blood glucose in wild-type and db/db mice at 8 and 24 wk of age (n = 4 each group). (D) Plasma C-Peptide in wild-type and db/db mice at 8 (n = 4) and 24 wk (n = 3) of age. (E) Plasma adiponectin in wild-type and db/db mice at 8 (n = 4) and 24 wk (n = 3) of age. (F) Blood triglycerides in wild-type and db/db mice at 8 (n = 4) and 24 wk (n = 3) of age. (G) Liver triglycerides in wild-type and db/db mice at 8 (n = 4) and 24 wk (n = 3) of age. (H) Blood cholesterol in wild-type and db/db mice at 8 (n = 4) and 24 wk (n = 3) of age. Data are represented by mean + SEM. Statistical significance between wild-type versus db/db: P < 0.05 (*), <0.01 (**), or <0.001 (***). (I) Cilia length of distal tubules cells in wild-type and db/db mice at 8 and 24 wk of age. Data are represented as median+IQr and range (n = 4).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Rotenone-induced reactive oxygen species production, but not cellular energy status and cell cycle, are responsible for elongating cilia in RPE1 cells.

    (A) Representative images of RPE1 cell line treated 48 h with DMSO vehicle or 400 nM rotenone. Cilia stained with anti-acetylated tubulin are indicated with white arrows. Scale bar = 5 μM. (B) Quantification of dose-dependent effect of rotenone on maximum and minimum cilia length in RPE1 cells. Data are represented by mean + CI; n = 3. (C) Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) normalized to the baseline after addition of different doses of rotenone and oligomycin in RPE1. Data are represented by mean + CI; n = 3. (D) Number of ciliated RPE1 after 48 h of 800 nM rotenone or 400 nM oligomycin versus DMSO vehicle control. Data are represented by mean + SD; n = 3. (E) Quantification of the median ciliary length in RPE1 treated as above. Data are represented by mean + SD; n = 3. (F) Quantification of the maximum ciliary length in RPE1 treated as above. Data are represented by mean + SD; n = 3. (G) ATP/ADP ratio normalized to the DMSO control in RPE1 cells treated 48 h as above. Data are represented by mean + SD; n = 3. (H) Cell cycle analysis in RPE1 cells treated as above. In the inset is displayed a representative image of cell cycle plot in control cells. Data are represented by mean + CI; n = 4. (I) Quantification of Mitosox intensity in RPE1 cells treated as above. Data are represented by mean + SD; n ≥ 5. (J) Quantification of median and maximum ciliary length in RPE1 cells treated with 10 nM rotenone in glucose-free galactose media. Data are represented by mean + SD; n = 3. Legend: Black empty = DMSO control; black = rotenone 800 nM; red = oligomycin 400 nM; gray = rotenone 10 nM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**). Rotenone versus oligomycin: P < 0.05 (#).

  • Figure S4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S4. Mitochondrial CI blockade elongates cilia in human retinal epithelial cells independently of cellular energy status.

    (A) Quantification of dose-dependent effect of rotenone on maximum and minimum cilia length in RPE1 cells. Data are represented by mean + CI; n = 12. (B) Quantification of dose-dependent effect of rotenone on median cilia length in RPE1 cells treated for 48 h. Data are represented by mean + CI; n = 12. Statistical significance was calculated using t test between DMSO control and any other rotenone dosage. (C) OCR normalized to the baseline in a representative experiment with acute additions of different doses of rotenone and oligomycin in RPE1 cells. Data are represented by mean + CI; n > 6. (D) Extracellular acidification rate (ECAR) normalized to the baseline in a representative experiment with acute additions of different doses of rotenone and oligomycin in RPE1. Data are represented by mean + CI; n > 6. (E) OCR and extracellular acidification rate (ECAR) normalized to the baseline after addition of different doses of rotenone and oligomycin in RPE1. Data are represented by mean + CI; n = 18. (F) Number of ciliated RPE1 after 48 h of 800 nM rotenone or 400 nM oligomycin versus DMSO vehicle control. Data are represented by mean + CI; n = 15. (G) Quantification of the median ciliary length in RPE1 treated as above. Data are represented by mean + CI; n = 15. (H) Quantification of the maximum ciliary length in RPE1 treated as above. Data are represented by mean + CI; n = 15. (I) ATP/ADP ratio normalized to the DMSO control in RPE1 cells treated 48 h as above. Data are represented by mean + CI; n > 5. (J) Cell cycle analysis in RPE1 cells treated as above. In the inset is displayed a representative image of cell cycle plot in control cells. Data are represented by mean + CI; n > 8. (K) Quantification of Mitosox intensity in RPE1 cells treated as above. Data are represented by mean + CI; n = 10. (L) Representation of flow cytometric histogram of RPE1 cells treated for 48 h with DMSO vehicle, 800 nM rotenone, or 400 nM oligomycin stained with Mitosox. Green: unstained, red: control, blue: rotenone, orange: oligomycin. (M) Representation of flow cytometric histogram of RPE1 cells treated as above and stained with DCFDA. Green: unstained, red: control, blue: rotenone, orange: oligomycin. (N) Quantification of DCFDA intensity in RPE1 cells treated as above normalized to control DMSO. Data are represented by mean + CI; n = 6. (O) Quantification of cilia number in IMCD3 cells treated for 48 h with 25 nM of rotenone in the presence of antioxidants (Tiron + Vit.C 1 mM, retinoic acid 1 μM). Data are represented by mean + CI; n = 14. (P) Quantification of median and maximum ciliary length in RPE1 cells treated with 10 nM rotenone in glucose-free galactose media. Data are represented by mean + CI; n = 10. Legend: Black empty = DMSO control; black = rotenone 800 nM; red = oligomycin 400 nM; gray = rotenone 10 nM. Statistical significance between control versus treatments: P < 0.05 (*), <0.01 (**), or <0.001 (***). Rotenone versus oligomycin: P < 0.05 (#), <0.01 (##), or <0.001 (###).

  • Figure S5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S5. Double ciliary staining in RPE1 cells.

    (A) Representative images of RPE1 cell line treated for 48 h with 800 nM rotenone or 400 nM oligomycin. The top left box represents the ciliary staining in single channels; blue: DAPI, green: acetylated tubulin, red: ARL13b.

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1.

    List of the 10 most represented mitochondrial proteins found in the ciliary database ordered by ciliary evidence (CiliaDB [Arnaiz et al, 2009]).

    NameCiliary evidenceOrganisms with ciliary evidenceNon flagellary evidenceProteomic studiesEvidence in H. sapiens
    Ubiquinol-cytochrome c reductase core protein II64330
    NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75 kD (NADH-coenzyme Q reductase)55211
    ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide55111
    Creatine kinase, mitochondrial 1B53221
    Isocitrate dehydrogenase 2 (NADP+), mitochondrial55331
    Inner membrane protein, mitochondrial54331
    Acyl-CoA dehydrogenase, short/branched chain52301
    Voltage-dependent anion channel 254430
    Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 344421
    Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 1043330

Supplementary Materials

  • Figures
  • Tables
  • Table S1 List of the antibodies used for Western Blotting and immunofluorescence staining. Primary antibodies in bold

  • Table S2 List of the primers used for qPCR.

PreviousNext
Back to top
Download PDF
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mitochondrial impairment and intracellular reactive oxygen species alter primary cilia morphology
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Energy and ROS affect primary cilia
Noah Moruzzi, Ismael Valladolid-Acebes, Sukanya A Kannabiran, Sara Bulgaro, Ingo Burtscher, Barbara Leibiger, Ingo B Leibiger, Per-Olof Berggren, Kerstin Brismar
Life Science Alliance Sep 2022, 5 (12) e202201505; DOI: 10.26508/lsa.202201505

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Energy and ROS affect primary cilia
Noah Moruzzi, Ismael Valladolid-Acebes, Sukanya A Kannabiran, Sara Bulgaro, Ingo Burtscher, Barbara Leibiger, Ingo B Leibiger, Per-Olof Berggren, Kerstin Brismar
Life Science Alliance Sep 2022, 5 (12) e202201505; DOI: 10.26508/lsa.202201505
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
Issue Cover

In this Issue

Volume 5, No. 12
December 2022
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results and Discussion
    • Materials and Methods
    • Data Availability
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Cell Biology
  • Metabolism
  • Physiology

Related Articles

  • No related articles found.

Cited By...

  • NEKL-4 regulates microtubule stability and mitochondrial health in C. elegans ciliated neurons
  • Google Scholar

More in this TOC Section

  • HU modulates thiol–disulfide homeostasis
  • GSK3A, a proviral host factor for HAdV-B7 replication
  • PSME3 regulates myogenesis
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Bluesky
  • X/Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2025 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.